S63845MCL1 inhibitor

S63845MCL1 inhibitor 

To Order Contact us: caitlyn@ucb-bioproducts.com

MAPKII Kinase Inhibitor (Hsp25 Kinase Inhibitor)
SIH-120A 1 mg
EUR 214.8
Description: The substance MAPKII Kinase Inhibitor is a hsp25 kinase inhibitor. It is synthetically produced and has a purity of >95%. The pure substance is white solid which is soluble in DMSO or H20.

Papain Inhibitor
A1035-25 25 mg
EUR 108
Description: Papain Inhibitor peptide,(C19H29N7O6),a peptide with the sequence H-Gly-Gly-Tyr-Arg-OH,MW= 451.4,this peptide Inhibits the peptidase activity of Papain.

Endotoxin Inhibitor
5-01105 4 x 1mg Ask for price

Kallikrein Inhibitor
5-01416 4 x 5mg Ask for price

Papain Inhibitor
5-01715 10mg Ask for price

Trypsin inhibitor
44R-1107 50 gram
EUR 4306.8
Description: Trypsin inhibitor enzyme

Renin Inhibitor
2084-25
EUR 1005.6

Renin Inhibitor
2084-5
EUR 314.4

Chk2 Inhibitor
1702-1
EUR 216

SCD1 Inhibitor
1716-1
EUR 261.6

SCD1 Inhibitor
1716-5
EUR 692.4

ACC2 Inhibitor
1717-1
EUR 261.6

ACC2 Inhibitor
1717-5
EUR 823.2

SIRT2 Inhibitor
1857-25
EUR 523.2

SIRT2 Inhibitor
1857-5
EUR 176.4

Elastase Inhibitor
1922-5
EUR 314.4

Myeloperoxidase Inhibitor
1977-100
EUR 138

Myeloperoxidase Inhibitor
1977-500
EUR 288

Syk Inhibitor
1983-1
EUR 151.2

Syk Inhibitor
1983-5
EUR 339.6

Apoptosis inhibitor
2783-25
EUR 548.4

Apoptosis inhibitor
2783-5
EUR 183.6

Elastase Inhibitor
A2579-5 5 mg
EUR 199.2
Description: A potent, irreversible inhibitor of human neutrophil elastase (HNE). The structure of the enzyme-inhibitor complex reveals crosslinking of the catalytic residues His-57 and Ser-195 by the peptidyl chloromethylketone.

BRAF inhibitor
A3263-10 10 mg
EUR 459.6
Description: BRAF inhibitor is a potent BRAF inhibitor.

BRAF inhibitor
A3263-5.1 10 mM (in 1mL DMSO)
EUR 537.6
Description: BRAF inhibitor is a potent BRAF inhibitor.

BRAF inhibitor
A3263-50 50 mg
EUR 1182
Description: BRAF inhibitor is a potent BRAF inhibitor.

CDK9 inhibitor
A3294-10 10 mg
EUR 393.6
Description: CDK9 inhibitor is a small-molecule selective inhibitor of CDK9 (cyclin dependent kinase 9) with IC50 value of 39 nM [1].CDKs are a group of serine/threonine kinases and are widely spread in all known eukaryotes.

CDK9 inhibitor
A3294-100 100 mg
EUR 1796.4
Description: CDK9 inhibitor is a small-molecule selective inhibitor of CDK9 (cyclin dependent kinase 9) with IC50 value of 39 nM [1].CDKs are a group of serine/threonine kinases and are widely spread in all known eukaryotes.

CDK9 inhibitor
A3294-5 5 mg
EUR 236.4
Description: CDK9 inhibitor is a small-molecule selective inhibitor of CDK9 (cyclin dependent kinase 9) with IC50 value of 39 nM [1].CDKs are a group of serine/threonine kinases and are widely spread in all known eukaryotes.

CDK9 inhibitor
A3294-5.1 10 mM (in 1mL DMSO)
EUR 254.4
Description: CDK9 inhibitor is a small-molecule selective inhibitor of CDK9 (cyclin dependent kinase 9) with IC50 value of 39 nM [1].CDKs are a group of serine/threonine kinases and are widely spread in all known eukaryotes.

CDK9 inhibitor
A3294-50 50 mg
EUR 1015.2
Description: CDK9 inhibitor is a small-molecule selective inhibitor of CDK9 (cyclin dependent kinase 9) with IC50 value of 39 nM [1].CDKs are a group of serine/threonine kinases and are widely spread in all known eukaryotes.

ITK inhibitor
A3509-10 10 mg
EUR 927.6
Description: Interleukin-2-inducible T cell kinase (ITK) is a non-receptor tyrosine kinase expressed in T cells, NKT cells and mast cells which plays a crucial role in regulating the T cell receptor (TCR), CD28, CD2, chemokine receptor CXCR4, and FcepsilonR-mediated signaling pathways.

ITK inhibitor
A3509-50 50 mg
EUR 2448
Description: Interleukin-2-inducible T cell kinase (ITK) is a non-receptor tyrosine kinase expressed in T cells, NKT cells and mast cells which plays a crucial role in regulating the T cell receptor (TCR), CD28, CD2, chemokine receptor CXCR4, and FcepsilonR-mediated signaling pathways.

NFAT Inhibitor
A4539-1 1 mg
EUR 165.6
Description: Selective inhibitor of calcineurin-mediated dephosphorylation of nuclear factor of activated T cells (NFAT). Does not disrupt other calcineurin-dependent pathways. Inhibits NFAT activation and NFAT-dependent expression of endogenous cytokine genes in T cells.

NFAT Inhibitor
A4539-10 10 mg
EUR 915.6
Description: Selective inhibitor of calcineurin-mediated dephosphorylation of nuclear factor of activated T cells (NFAT). Does not disrupt other calcineurin-dependent pathways. Inhibits NFAT activation and NFAT-dependent expression of endogenous cytokine genes in T cells.

NFAT Inhibitor
A4539-5 5 mg
EUR 540
Description: Selective inhibitor of calcineurin-mediated dephosphorylation of nuclear factor of activated T cells (NFAT). Does not disrupt other calcineurin-dependent pathways. Inhibits NFAT activation and NFAT-dependent expression of endogenous cytokine genes in T cells.

Rinbonuclease Inhibitor
abx098030-10kU 10 kU
EUR 644.4

Rinbonuclease Inhibitor
abx098030-2kU 2 kU
EUR 510

Lck Inhibitor
A3539-1 1 mg
EUR 184.8
Description: Lck Inhibitor is a small-molecule inhibitor of with IC50 value of 7 nM [1].The lymphocyte specific kinase which expressed in NK cells and T-cells is a member of the Src kinase family.

Lck Inhibitor
A3539-5 5 mg
EUR 266.4
Description: Lck Inhibitor is a small-molecule inhibitor of with IC50 value of 7 nM [1].The lymphocyte specific kinase which expressed in NK cells and T-cells is a member of the Src kinase family.

MEK inhibitor
A3594-10 10 mg
EUR 895.2
Description: A potent MEK inhibitor, Antitumor agent.

MEK inhibitor
A3594-5 5 mg
EUR 656.4
Description: A potent MEK inhibitor, Antitumor agent.

MEK inhibitor
A3594-5.1 10 mM (in 1mL DMSO)
EUR 717.6
Description: A potent MEK inhibitor, Antitumor agent.

PDK1 inhibitor
A3706-10 10 mg
EUR 594
Description: PDK1 inhibitor is an potent and selective inhibitor of PDK1 with potential as anticancer agent. GSK 2334470,a inhibitor of PDK1, has IC50 value of 0.00251µM and CHEMBL1172241 with IC50 value of 0.085µM.

PDK1 inhibitor
A3706-100 100 mg
EUR 3099.6
Description: PDK1 inhibitor is an potent and selective inhibitor of PDK1 with potential as anticancer agent. GSK 2334470,a inhibitor of PDK1, has IC50 value of 0.00251µM and CHEMBL1172241 with IC50 value of 0.085µM.

PDK1 inhibitor
A3706-5 5 mg
EUR 348
Description: PDK1 inhibitor is an potent and selective inhibitor of PDK1 with potential as anticancer agent. GSK 2334470,a inhibitor of PDK1, has IC50 value of 0.00251µM and CHEMBL1172241 with IC50 value of 0.085µM.

PDK1 inhibitor
A3706-50 50 mg
EUR 2067.6
Description: PDK1 inhibitor is an potent and selective inhibitor of PDK1 with potential as anticancer agent. GSK 2334470,a inhibitor of PDK1, has IC50 value of 0.00251µM and CHEMBL1172241 with IC50 value of 0.085µM.

Apoptosis Inhibitor
A1930-10 10 mg
EUR 170.4
Description: M50054, 2,2'-methylenebis (1,3-cyclohexanedione), is a novel inhibitor of apoptosis. [1] In human Fas-expressing WC8 cells, M50054 inhibited apoptosis by soluble human Fas ligand in vitro cell death assay.

Apoptosis Inhibitor
A1930-100 100 mg
EUR 547.2
Description: M50054, 2,2'-methylenebis (1,3-cyclohexanedione), is a novel inhibitor of apoptosis. [1] In human Fas-expressing WC8 cells, M50054 inhibited apoptosis by soluble human Fas ligand in vitro cell death assay.

Apoptosis Inhibitor
A1930-25 25 mg
EUR 282
Description: M50054, 2,2'-methylenebis (1,3-cyclohexanedione), is a novel inhibitor of apoptosis. [1] In human Fas-expressing WC8 cells, M50054 inhibited apoptosis by soluble human Fas ligand in vitro cell death assay.

Apoptosis Inhibitor
A1930-5.1 10 mM (in 1mL DMSO)
EUR 129.6
Description: M50054, 2,2'-methylenebis (1,3-cyclohexanedione), is a novel inhibitor of apoptosis. [1] In human Fas-expressing WC8 cells, M50054 inhibited apoptosis by soluble human Fas ligand in vitro cell death assay.

Apoptosis Inhibitor
A1930-S Evaluation Sample
EUR 97.2
Description: M50054, 2,2'-methylenebis (1,3-cyclohexanedione), is a novel inhibitor of apoptosis. [1] In human Fas-expressing WC8 cells, M50054 inhibited apoptosis by soluble human Fas ligand in vitro cell death assay.

Stat5 Inhibitor
9484-1
EUR 144

Stat5 Inhibitor
9484-5
EUR 392.4

Trypsin inhibitor
AG160 1 mg
EUR 627.6

CDK4 inhibitor
B1233-10 10 mg
EUR 562.8
Description: CDK4 inhibitor is a selective inhibitor of cyclin-dependent kinase 4 with IC50 value of 10 nM [1].Cyclin-dependent kinase 4 (CDK4) is a Ser/Thr protein kinase and is a member of the cyclin-dependent kinase family.

CDK4 inhibitor
B1233-100 100 mg
EUR 1910.4
Description: CDK4 inhibitor is a selective inhibitor of cyclin-dependent kinase 4 with IC50 value of 10 nM [1].Cyclin-dependent kinase 4 (CDK4) is a Ser/Thr protein kinase and is a member of the cyclin-dependent kinase family.

CDK4 inhibitor
B1233-25 25 mg
EUR 787.2
Description: CDK4 inhibitor is a selective inhibitor of cyclin-dependent kinase 4 with IC50 value of 10 nM [1].Cyclin-dependent kinase 4 (CDK4) is a Ser/Thr protein kinase and is a member of the cyclin-dependent kinase family.

CDK4 inhibitor
B1233-5 5 mg
EUR 390
Description: CDK4 inhibitor is a selective inhibitor of cyclin-dependent kinase 4 with IC50 value of 10 nM [1].Cyclin-dependent kinase 4 (CDK4) is a Ser/Thr protein kinase and is a member of the cyclin-dependent kinase family.

CDK4 inhibitor
B1233-50 50 mg
EUR 1249.2
Description: CDK4 inhibitor is a selective inhibitor of cyclin-dependent kinase 4 with IC50 value of 10 nM [1].Cyclin-dependent kinase 4 (CDK4) is a Ser/Thr protein kinase and is a member of the cyclin-dependent kinase family.

PKM2 Inhibitor
B2593-25
EUR 757.2

PKM2 Inhibitor
B2593-5
EUR 235.2

Trypsin inhibitor
AT160 1mg
EUR 1641.6

PI3K-? Inhibitor
B1869-25
EUR 810

PI3K-? Inhibitor
B1869-5
EUR 248.4

EGFR Inhibitor
C3327-1 1 mg
EUR 184.8
Description: EGFR inhibitor is a cell permeable, pyrimidine compound that selectively inhibits the EGFR kinase with IC50 value of 21 nM [1]. EGFR is a transmembrane protein, and is a receptor for members of epidermal growth factor family.

EGFR Inhibitor
C3327-25 25 mg
EUR 1375.2
Description: EGFR inhibitor is a cell permeable, pyrimidine compound that selectively inhibits the EGFR kinase with IC50 value of 21 nM [1]. EGFR is a transmembrane protein, and is a receptor for members of epidermal growth factor family.

EGFR Inhibitor
C3327-5 5 mg
EUR 435.6
Description: EGFR inhibitor is a cell permeable, pyrimidine compound that selectively inhibits the EGFR kinase with IC50 value of 21 nM [1]. EGFR is a transmembrane protein, and is a receptor for members of epidermal growth factor family.

CBF? Inhibitor
C3398-10 10 mg
EUR 243.6
Description: CBF? inhibitor is a small molecule which binds to CBF? and inhibits its association with Runx1 [1].Core binding factors (CBFs) are heterodimeric transcription factors containing a DNA-binding CBF? component (a RUNX protein) and an enhancer of binding, CBF?.

CBF? Inhibitor
C3398-25 25 mg
EUR 471.6
Description: CBF? inhibitor is a small molecule which binds to CBF? and inhibits its association with Runx1 [1].Core binding factors (CBFs) are heterodimeric transcription factors containing a DNA-binding CBF? component (a RUNX protein) and an enhancer of binding, CBF?.

CBF? Inhibitor
C3398-5 5 mg
EUR 157.2
Description: CBF? inhibitor is a small molecule which binds to CBF? and inhibits its association with Runx1 [1].Core binding factors (CBFs) are heterodimeric transcription factors containing a DNA-binding CBF? component (a RUNX protein) and an enhancer of binding, CBF?.

PKR Inhibitor
C4439-10 10 mg
EUR 247.2
Description: IC50: 186-210 nMPKR Inhibitor is a double-stranded RNA-activated protein kinase (PKR) inhibitor. Initiation of protein synthesis is reported to be regulated by kinase-dependent phosphorylation reactions.

PKR Inhibitor
C4439-25 25 mg
EUR 477.6
Description: IC50: 186-210 nMPKR Inhibitor is a double-stranded RNA-activated protein kinase (PKR) inhibitor. Initiation of protein synthesis is reported to be regulated by kinase-dependent phosphorylation reactions.

PKR Inhibitor
C4439-5 5 mg
EUR 164.4
Description: IC50: 186-210 nMPKR Inhibitor is a double-stranded RNA-activated protein kinase (PKR) inhibitor. Initiation of protein synthesis is reported to be regulated by kinase-dependent phosphorylation reactions.

STAT5 Inhibitor
C4105-10 10 mg
EUR 235.2
Description: STAT5 Inhibitor is a cell-permeable inhibitor of STAT5 with IC50 value of 47 ?M against STAT5? SH2 domain EPO peptide binding activity [1].

STAT5 Inhibitor
C4105-25 25 mg
EUR 451.2
Description: STAT5 Inhibitor is a cell-permeable inhibitor of STAT5 with IC50 value of 47 ?M against STAT5? SH2 domain EPO peptide binding activity [1].

STAT5 Inhibitor
C4105-5 5 mg
EUR 151.2
Description: STAT5 Inhibitor is a cell-permeable inhibitor of STAT5 with IC50 value of 47 ?M against STAT5? SH2 domain EPO peptide binding activity [1].

miRNA Inhibitor
M1265-10
EUR 666

miRNA Inhibitor
M1265-2
EUR 424.8

miRNA Inhibitor
M1265-3
EUR 451.2

miRNA Inhibitor
M1265-4
EUR 489.6

miRNA Inhibitor
M1265-5
EUR 516

miRNA Inhibitor
M1265-6
EUR 542.4

miRNA Inhibitor
M1265-7
EUR 568.8

miRNA Inhibitor
M1265-8
EUR 594

miRNA Inhibitor
M1265-9
EUR 633.6

XL647Kinase Inhibitor
E1KS1083 5 mg
EUR 1047.6

Nav1.7 inhibitor
HY-13985 10mM/1mL
EUR 696

PLpro inhibitor
HY-17542 5mg
EUR 639.6

CPA inhibitor
HY-70005 50mg
EUR 1556.4

BRAF inhibitor
HY-10247 10mM/1mL
EUR 424.8

NFAT Inhibitor
HY-P1026 5mg
EUR 523.2

DDR Inhibitor
HY-W018931 10mM/1mL
EUR 1197.6

Neurotoxin Inhibitor
HY-112722 10mM/1mL
EUR 892.8

S63845MCL1 inhibitor

Site Title, Some rights reserved.

Terms of Use - Privacy Policy

WordPress Di Blog Theme